What has the pandemic revealed about the US health care system — and what needs to change?
Seven MIT researchers see lessons and opportunities for US health care.
Why we need a more precise understanding of vaccine hesitation
In a Q&A, Charles Senteio discusses Covid-19 vaccine hesitancy among Black Americans and the “tsunami of inequity” accelerated by the pandemic.
Supporting the Covid-19 vaccine rollout with extra-strength glass
Corning executive Mark Kurz SM ’95 leads a team producing vials for vaccine distribution.
Vaccination by inhalation
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
3 Questions: Vaccines and the power of positive reinforcement
Experts say people are more willing to get the Covid-19 vaccine when told how popular it is.
Study: Covid-19 communications featuring racially diverse physicians can improve health outcomes for communities of color
Improved public health messaging to Black, Latinx, and other communities disproportionately impacted by the pandemic can increase Covid-19 knowledge and information-seeking.
Building equity into vaccine distribution
MIT economist works to show how therapies can be allocated fairly; states are now applying the method in their efforts.
MIT developing framework for Covid-19 vaccinations on campus
State grants approval for Institute to help in vaccinating approximately 50,000 students, employees, affiliates, and dependents.
Understanding antibodies to avoid pandemics
Structural biologist Pamela Björkman shared insights into pandemic viruses as part of the Department of Biology’s IAP seminar series.
Designing in a pandemic to fight a pandemic
The capstone senior design class in biological engineering, 20.380 (Biological Engineering Design), took on its most immediate challenge ever.
Model analyzes how viruses escape the immune system
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Featured video: Covid-19 vaccines arrive at MIT
By the end of 2020, a first dose was administered to every at-risk staff member of MIT Medical who requested a vaccine.
3 Questions: Phillip Sharp on the discoveries that enabled RNA vaccines for Covid-19
Curiosity-driven basic science in the 1970s laid the groundwork for today’s leading vaccines against the novel coronavirus.
Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
3 Questions: Ram Sasisekharan on hastening vaccines and treatments
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.